Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1990 Oct;86(4):1038–1045. doi: 10.1172/JCI114806

Synergism between hepatic injuries and a nonhepatotropic reovirus in mice. Enhanced hepatic infection and death.

D A Piccoli 1, C L Witzleben 1, C J Guico 1, A Morrison 1, D H Rubin 1
PMCID: PMC296830  PMID: 2170443

Abstract

Reovirus type 1, after intravenous inoculation in the adult mouse, is secreted via bile into the intestine in an infectious form. Although reovirus type 1 is rapidly removed from systemic circulation by the liver and the lung, very few hepatocytes express reovirus antigen during infection. In intestinal cells, reovirus replicates selectively in the crypts. This site preference may be due to active cell proliferation in the crypts. We hypothesized that the state of the cell may affect virus replication and tested this hypothesis by using chemical and surgical means to increase hepatic mitotic activity. Adult mice were treated with carbon tetrachloride or surgical trauma, inoculated with reovirus type 1 intravenously, and subsequently killed. Virus antigen was identified using a highly specific immunohistochemical technique. Liver sections were stained using immunoperoxidase with specific rabbit antireovirus antibody. Hepatotoxin and surgical trauma increase reovirus antigen detection in both Kupffer cells and hepatocytes. Only the sequential administration of CCl4 and virus caused mortality at doses sublethal for each alone. These data demonstrate a synergism between hepatic injury and reovirus which results in a significant increase in the magnitude of viral infection and contributes to mortality. Such synergism may be important in idiopathic liver disease.

Full text

PDF
1038

Images in this article

1040Image
on p.1040
1040Image
on p.1040
1040Image
on p.1040
1040Image
on p.1040
1042Image
on p.1042
1043Image
on p.1043

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bangaru B., Morecki R., Glaser J. H., Gartner L. M., Horwitz M. S. Comparative studies of biliary atresia in the human newborn and reovirus-induced cholangitis in weanling mice. Lab Invest. 1980 Nov;43(5):456–462. [PubMed] [Google Scholar]
  2. Brown W. R., Sokol R. J., Levin M. J., Silverman A., Tamaru T., Lilly J. R., Hall R. J., Cheney M. Lack of correlation between infection with reovirus 3 and extrahepatic biliary atresia or neonatal hepatitis. J Pediatr. 1988 Oct;113(4):670–676. doi: 10.1016/s0022-3476(88)80376-7. [DOI] [PubMed] [Google Scholar]
  3. Bukowski J. F., Woda B. A., Habu S., Okumura K., Welsh R. M. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J Immunol. 1983 Sep;131(3):1531–1538. [PubMed] [Google Scholar]
  4. David H., Reinke P. The concept of the "perisinusoidal functional unit" of the liver--importance to pathological processes. Exp Pathol. 1987;32(4):193–224. doi: 10.1016/s0232-1513(87)80031-2. [DOI] [PubMed] [Google Scholar]
  5. Duncan M. R., Stanish S. M., Cox D. C. Differential sensitivity of normal and transformed human cells to reovirus infection. J Virol. 1978 Nov;28(2):444–449. doi: 10.1128/jvi.28.2.444-449.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Enzan H. Proliferation of Ito cells (fat-storing cells) in acute carbon tetrachloride liver injury. A light and electron microscopic autoradiographic study. Acta Pathol Jpn. 1985 Nov;35(6):1301–1308. doi: 10.1111/j.1440-1827.1985.tb01429.x. [DOI] [PubMed] [Google Scholar]
  7. Fabrikant J. I. The kinetics of cellular proliferation in regenerating liver. J Cell Biol. 1968 Mar;36(3):551–565. doi: 10.1083/jcb.36.3.551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Glaser J. H., Morecki R. Reovirus type 3 and neonatal cholestasis. Semin Liver Dis. 1987 May;7(2):100–107. doi: 10.1055/s-2008-1040569. [DOI] [PubMed] [Google Scholar]
  9. Hagmann W., Steffan A. M., Kirn A., Keppler D. Leukotrienes as mediators in frog virus 3-induced hepatitis in rats. Hepatology. 1987 Jul-Aug;7(4):732–736. doi: 10.1002/hep.1840070419. [DOI] [PubMed] [Google Scholar]
  10. Hsu S. M., Raine L., Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol. 1981 Jun;75(6):816–821. doi: 10.1093/ajcp/75.6.816. [DOI] [PubMed] [Google Scholar]
  11. Kauffman R. S., Wolf J. L., Finberg R., Trier J. S., Fields B. N. The sigma 1 protein determines the extent of spread of reovirus from the gastrointestinal tract of mice. Virology. 1983 Jan 30;124(2):403–410. doi: 10.1016/0042-6822(83)90356-2. [DOI] [PubMed] [Google Scholar]
  12. Kirn A., Gut J. P., Bingen A., Steffan A. M. Murine hepatitis induced by frog virus 3: a model for studying the effect of sinusoidal cell damage on the liver. Hepatology. 1983 Jan-Feb;3(1):105–111. doi: 10.1002/hep.1840030117. [DOI] [PubMed] [Google Scholar]
  13. Klavinskis L. S., Oldstone M. B. Lymphocytic choriomeningitis virus selectively alters differentiated but not housekeeping functions: block in expression of growth hormone gene is at the level of transcriptional initiation. Virology. 1989 Feb;168(2):232–235. doi: 10.1016/0042-6822(89)90262-6. [DOI] [PubMed] [Google Scholar]
  14. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  15. Lipkin W. I., Battenberg E. L., Bloom F. E., Oldstone M. B. Viral infection of neurons can depress neurotransmitter mRNA levels without histologic injury. Brain Res. 1988 Jun 7;451(1-2):333–339. doi: 10.1016/0006-8993(88)90779-2. [DOI] [PubMed] [Google Scholar]
  16. Minuk G. Y., Rascanin N., Paul R. W., Lee P. W., Buchan K., Kelly J. K. Reovirus type 3 infection in patients with primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol. 1987 Aug;5(1):8–13. doi: 10.1016/s0168-8278(87)80054-5. [DOI] [PubMed] [Google Scholar]
  17. Nakata R., Tsukamoto I., Miyoshi M., Kojo S. Liver regeneration after carbon tetrachloride intoxication in the rat. Biochem Pharmacol. 1985 Feb 15;34(4):586–588. doi: 10.1016/0006-2952(85)90195-9. [DOI] [PubMed] [Google Scholar]
  18. Nemerow G. R., McNaughton M. E., Cooper N. R. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes. J Immunol. 1985 Nov;135(5):3068–3073. [PubMed] [Google Scholar]
  19. Ogawa K., Suzuki J., Narasaki M., Mori M. Healing of focal injury in the rat liver. Am J Pathol. 1985 Apr;119(1):158–167. [PMC free article] [PubMed] [Google Scholar]
  20. Panduro A., Shalaby F., Weiner F. R., Biempica L., Zern M. A., Shafritz D. A. Transcriptional switch from albumin to alpha-fetoprotein and changes in transcription of other genes during carbon tetrachloride induced liver regeneration. Biochemistry. 1986 Mar 25;25(6):1414–1420. doi: 10.1021/bi00354a034. [DOI] [PubMed] [Google Scholar]
  21. ROSEN L., ABINANTI F. R. Natural and experimental infection of catle with human types of reoviruses. Am J Hyg. 1960 Mar;71:250–257. doi: 10.1093/oxfordjournals.aje.a120108. [DOI] [PubMed] [Google Scholar]
  22. Ramig R. F., Cross R. K., Fields B. N. Genome RNAs and polypeptides of reovirus serotypes 1, 2, and 3. J Virol. 1977 Jun;22(3):726–733. doi: 10.1128/jvi.22.3.726-733.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rubin D. H., Eaton M. A., Anderson A. O. Reovirus infection in adult mice: the virus hemagglutinin determines the site of intestinal disease. Microb Pathog. 1986 Feb;1(1):79–87. doi: 10.1016/0882-4010(86)90034-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rubin D. H., Eaton M. A., Costello T. Reovirus type 1 is secreted into the bile. J Virol. 1986 Nov;60(2):726–728. doi: 10.1128/jvi.60.2.726-728.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Rubin D. H., Kornstein M. J., Anderson A. O. Reovirus serotype 1 intestinal infection: a novel replicative cycle with ileal disease. J Virol. 1985 Feb;53(2):391–398. doi: 10.1128/jvi.53.2.391-398.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Rubin D. H. Reovirus serotype 1 binds to the basolateral membrane of intestinal epithelial cells. Microb Pathog. 1987 Sep;3(3):215–219. doi: 10.1016/0882-4010(87)90098-2. [DOI] [PubMed] [Google Scholar]
  27. STOWELL R. E., LEE C. S. Histochemical studies of mouse liver after single feeding of carbon tetrachloride. AMA Arch Pathol. 1950 Nov;50(5):519–537. [PubMed] [Google Scholar]
  28. Smith R. E., Zweerink H. J., Joklik W. K. Polypeptide components of virions, top component and cores of reovirus type 3. Virology. 1969 Dec;39(4):791–810. doi: 10.1016/0042-6822(69)90017-8. [DOI] [PubMed] [Google Scholar]
  29. Spriggs D. R., Bronson R. T., Fields B. N. Hemagglutinin variants of reovirus type 3 have altered central nervous system tropism. Science. 1983 Apr 29;220(4596):505–507. doi: 10.1126/science.6301010. [DOI] [PubMed] [Google Scholar]
  30. Tardieu M., Powers M. L., Weiner H. L. Age dependent susceptibility to Reovirus type 3 encephalitis: role of viral and host factors. Ann Neurol. 1983 Jun;13(6):602–607. doi: 10.1002/ana.410130604. [DOI] [PubMed] [Google Scholar]
  31. Verdin E. M., Maratos-Flier E., Kahn C. R., Sodoyez J. C., Sodoyez-Goffaux F., De Vos C. J., Lynn S. P., Fields B. N. Visualization of viral clearance in the living animal. Science. 1987 Apr 24;236(4800):439–442. doi: 10.1126/science.3031817. [DOI] [PubMed] [Google Scholar]
  32. WALTERS M. N., LEAK P. J., JOSKE R. A., STANLEY N. F., PERRET D. H. MURINE INFECTION WITH REOVIRUS. 3. PATHOLOGY OF INFECTION WITH TYPES 1 AND 2. Br J Exp Pathol. 1965 Apr;46:200–212. [PMC free article] [PubMed] [Google Scholar]
  33. Wolf J. L., Rubin D. H., Finberg R., Kauffman R. S., Sharpe A. H., Trier J. S., Fields B. N. Intestinal M cells: a pathway for entry of reovirus into the host. Science. 1981 Apr 24;212(4493):471–472. doi: 10.1126/science.6259737. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES